Moreover, dobutamine treatment already showed its anti-inflammatory effects through TNF-α and IL-6 reduction in rats with endotoxemia and in septic shock patients [79,80]; however, in this study, for the first time, we demonstrated that this reduction is associated with NF-κB downregulation. The gene discussed is NFKB1; the disease is serum lipopolysaccharide activity.